You are here

Irwin Naturals Inc. - Subordinate Voting Shares

Irwin Naturals Inc. - Subordinate Voting Shares
Listing Exchange: 
CSE
Status: 
Suspended
Industry: 
Life Sciences
Symbol: 
IWIN
CSE Index: 
Currency: 

Irwin Naturals is a nutraceutical company that distributes dietary supplements to more than 100,000 retailers, including mass-market retailers.

Investor Note: In addition to the 3,369,368 Subordinate Voting Shares that are listed and trading, there are (i) 340,300 subordinate voting shares reserved for issuance pursuant to the conversion rights attached to the Proportionate Voting Shares of Irwin Naturals Inc. (ii) 18,240 subordinate voting shares reserved for issuance pursuant to the conversion rights attached to the Multiple Voting Shares of Irwin Naturals Inc.; (iii) 303,999,878 subordinate voting shares reserved for issuance pursuant to the exchange rights attached to the Class B Non-Voting Shares of Irwin Naturals, an indirect, wholly-owned subsidiary of Irwin Naturals Inc.; and (iv) 20,000 subordinate voting share purchase warrants.  The total number of equity shares assuming all are converted or exchanged, as applicable, into the listed class would be 307,747,786.

You are here

Irwin Naturals Inc. - Subordinate Voting Shares (IWIN)

SEDAR Information

Company Info

Address
5310 Beethoven St.
Los Angeles, CA 90066
United States
Phone
310-306-3636
Email
[email protected]
Website
https://irwinnaturals.com/
Listing date
Tuesday, August 17, 2021
Transfer Agent
Odyssey Trust Company

Capitalization

Issued & Outstanding: 
3369368
Reserved for Issuance: 
304378418
Total equity shares, as if converted: 
307747786

Company Officers

Klee Irwin , CEO
Mark Green, Chief Financial Officer and Corporate Secretary

Bulletins

07/05/2024

2024-0508 - Suspensions - BIO, FABL, HMPS, IWIN

le 7 mai/Mai 2024

Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101 Trading Rules. Cease Trade Orders have been issued by one or more securities commissions.